Historical Valuation
Organon & Co (OGN) is now in the Undervalued zone, suggesting that its current forward PE ratio of 1.88 is considered Undervalued compared with the five-year average of 4.77. The fair price of Organon & Co (OGN) is between 41.51 to 51.66 according to relative valuation methord. Compared to the current price of 8.05 USD , Organon & Co is Undervalued By 80.61%.
Relative Value
Fair Zone
41.51-51.66
Current Price：8.05
80.61%
Undervalued
P/E
EV/EBITDA
EV/EBIT
P/S
P/OCF
P/FCF
1Y
3Y
5Y
Trailing
Forward
Organon & Co (OGN) has a current Price-to-Book (P/B) ratio of 2.08. Compared to its 3-year average P/B ratio of 7.35 , the current P/B ratio is approximately -71.72% higher. Relative to its 5-year average P/B ratio of 2.78, the current P/B ratio is about -25.33% higher. Organon & Co (OGN) has a Forward Free Cash Flow (FCF) yield of approximately 41.28%. Compared to its 3-year average FCF yield of 17.55%, the current FCF yield is approximately 135.18% lower. Relative to its 5-year average FCF yield of 18.34% , the current FCF yield is about 125.07% lower.
P/B
Median3y
7.35
Median5y
2.78
FCF Yield
Median3y
17.55
Median5y
18.34
Competitors Valuation Multiple
AI Analysis for OGN
The average P/S ratio for OGN competitors is 448.91, providing a benchmark for relative valuation. Organon & Co Corp (OGN.N) exhibits a P/S ratio of 0.31, which is -99.93% above the industry average. Given its robust revenue growth of 1.26%, this premium appears unsustainable.
Performance Decomposition
AI Analysis for OGN
1Y
3Y
5Y
Market capitalization of OGN increased by 0.00% over the past 1 year. The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.
The secondary factor is the Unknown, contributed 0.00%to the performance.
Overall, the performance of OGN in the past 1 year is driven by Unknown.
People Also Watch
Frequently Asked Questions
Is OGN currently overvalued or undervalued?
Organon & Co (OGN) is now in the Undervalued zone, suggesting that its current forward PE ratio of 1.88 is considered Undervalued compared with the five-year average of 4.77. The fair price of Organon & Co (OGN) is between 41.51 to 51.66 according to relative valuation methord. Compared to the current price of 8.05 USD , Organon & Co is Undervalued By 80.61% .
What is Organon & Co (OGN) fair value?
OGN's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average , adjusted by weights. The fair price of Organon & Co (OGN) is between 41.51 to 51.66 according to relative valuation methord.
How does OGN's valuation metrics compare to the industry average?
The average P/S ratio for OGN's competitors is 448.91, providing a benchmark for relative valuation. Organon & Co Corp (OGN) exhibits a P/S ratio of 0.31, which is -99.93% above the industry average. Given its robust revenue growth of 1.26%, this premium appears unsustainable.
What is the current P/B ratio for Organon & Co (OGN) as of Jan 10 2026?
As of Jan 10 2026, Organon & Co (OGN) has a P/B ratio of 2.08. This indicates that the market values OGN at 2.08 times its book value.
What is the current FCF Yield for Organon & Co (OGN) as of Jan 10 2026?
As of Jan 10 2026, Organon & Co (OGN) has a FCF Yield of 41.28%. This means that for every dollar of Organon & Co’s market capitalization, the company generates 41.28 cents in free cash flow.
What is the current Forward P/E ratio for Organon & Co (OGN) as of Jan 10 2026?
As of Jan 10 2026, Organon & Co (OGN) has a Forward P/E ratio of 1.88. This means the market is willing to pay $1.88 for every dollar of Organon & Co’s expected earnings over the next 12 months.
What is the current Forward P/S ratio for Organon & Co (OGN) as of Jan 10 2026?
As of Jan 10 2026, Organon & Co (OGN) has a Forward P/S ratio of 0.31. This means the market is valuing OGN at $0.31 for every dollar of expected revenue over the next 12 months.